I need a procedure - Revision history

Cjg38: /* GI / GU Fluoro Studies */

2026-04-20T22:03:43Z

‎GI / GU Fluoro Studies

Nathan.brajer: /* I need a procedure: Steps for ordering clinicians */

2024-10-09T19:33:43Z

‎I need a procedure: Steps for ordering clinicians

Nathan.brajer: /* I need a procedure: Steps for ordering clinicians */

2024-10-09T19:32:58Z

‎I need a procedure: Steps for ordering clinicians

Nathan.brajer: /* I need a procedure: Steps for ordering clinicians */

2024-10-09T19:32:49Z

‎I need a procedure: Steps for ordering clinicians

Nathan.brajer at 19:31, 9 October 2024

2024-10-09T19:31:19Z

Nathan.brajer at 19:30, 9 October 2024

2024-10-09T19:30:46Z

Nathan.brajer: /* Peri-procedural Anticoagulation Guidelines */

2024-10-09T19:24:49Z

‎Peri-procedural Anticoagulation Guidelines

Nathan.brajer: /* Peri-procedural Anticoagulation Guidelines */

2024-10-09T19:24:16Z

‎Peri-procedural Anticoagulation Guidelines

Nathan.brajer: /* Peri-procedural Anticoagulation Guidelines */

2024-10-09T19:23:52Z

‎Peri-procedural Anticoagulation Guidelines

Nathan.brajer: /* Peri-procedural Anticoagulation Guidelines */

2024-10-09T19:23:34Z

‎Peri-procedural Anticoagulation Guidelines

@@ Line 88: / Line 88: @@
 '''PROCEDURES:'''
-*Imaging-guided Dobhoff tube placements (after failed attempt on floor)
+*Imaging-guided Dobhoff tube placements (after failed attempt on floor) - Please make patient NPO for 6 hours prior to procedure
 *Esophagrams, Upper GI studies (evaluate through the ligament of Trietz), and small bowel follow throughs (for intestinal motility)
 *Contrast enemas (water-soluble contrast for leaks, barium for pre G-tube placement)

@@ Line 8: / Line 8: @@
 . Determine procedural bleeding risk, manage anticoagulation/anti-platelet medications, and correct for Plt and INR goal.
-''The Radiologist will discuss #2 through #4 with you''
+''The Radiologist will discuss #2 through #4 with you.''
 == Who and How to Call: Body, VIR, GI, Neuro, Peds, MSK, or Chest ==

@@ Line 8: / Line 8: @@
 . Determine procedural bleeding risk, manage anticoagulation/anti-platelet medications, and correct for Plt and INR goal.
-''The radiologist will discuss #2 through #4 with you''
+''The Radiologist will discuss #2 through #4 with you''
 == Who and How to Call: Body, VIR, GI, Neuro, Peds, MSK, or Chest ==

@@ Line 6: / Line 6: @@
 . Labs obtained?
-. Determine procedural bleeding risk, manage anticoagulation/anti-platelet medications, correct for Plt and INR goal.
+. Determine procedural bleeding risk, manage anticoagulation/anti-platelet medications, and correct for Plt and INR goal.
 == Who and How to Call: Body, VIR, GI, Neuro, Peds, MSK, or Chest ==

@@ Line 1: / Line 1: @@
-==I need a procedure: steps==
+==I need a procedure: Steps for ordering clinicians==
 . Determine which radiology division to call, and how to call them.
 . Contrast allergy prep needed?
 . Labs obtained?
 . Determine procedural bleeding risk, manage anticoagulation/anti-platelet medications, correct for Plt and INR goal.
 == Who and How to Call: Body, VIR, GI, Neuro, Peds, MSK, or Chest ==
 ===[https://docs.google.com/spreadsheets/d/1HRS1m1oEDTWGatOQg07zLdlaJfM6G91zmAzB83bcWGA/edit#gid=1117733968 Who to Call Spreadsheet] & [https://docs.google.com/spreadsheets/d/1_-NkLTiYR70_rWGI4X2S74GP1QkruqMGBy4XwsCkZ3w/edit?usp=sharing Procedure Orders Spreadsheet]===

← Older revision		Revision as of 19:30, 9 October 2024
Line 1:		Line 1:
		+	==I need a procedure: steps==
		+	1. Determine which radiology division to call, and how to call them.
		+	2. Contrast allergy prep needed?
		+	3. Labs obtained?
		+	4. Determine procedural bleeding risk, manage anticoagulation/anti-platelet medications, correct for Plt and INR goal.
	== Who and How to Call: Body, VIR, GI, Neuro, Peds, MSK, or Chest ==		== Who and How to Call: Body, VIR, GI, Neuro, Peds, MSK, or Chest ==
	===[https://docs.google.com/spreadsheets/d/1HRS1m1oEDTWGatOQg07zLdlaJfM6G91zmAzB83bcWGA/edit#gid=1117733968 Who to Call Spreadsheet] & [https://docs.google.com/spreadsheets/d/1_-NkLTiYR70_rWGI4X2S74GP1QkruqMGBy4XwsCkZ3w/edit?usp=sharing Procedure Orders Spreadsheet]===		===[https://docs.google.com/spreadsheets/d/1HRS1m1oEDTWGatOQg07zLdlaJfM6G91zmAzB83bcWGA/edit#gid=1117733968 Who to Call Spreadsheet] & [https://docs.google.com/spreadsheets/d/1_-NkLTiYR70_rWGI4X2S74GP1QkruqMGBy4XwsCkZ3w/edit?usp=sharing Procedure Orders Spreadsheet]===

@@ Line 14: / Line 14: @@
 == Peri-procedural Anticoagulation Guidelines ==
-. Determine procedure bleeding risk (low or high; see Bleeding Risk Categorization below)
+'''1. Determine procedure bleeding risk''' (low or high; see Bleeding Risk Categorization below)
-. Determine needed labs and Platelet/INR goals (see Laboratory Values below).
+'''2. Determine needed labs and Platelet/INR goals''' (see Laboratory Values below).
-. Refer to anticoagulation guidelines based on procedure risk category (see Management of Medications below).
+'''3. Refer to anticoagulation guidelines based on procedure risk category''' (see Management of Medications below).
 These guidelines, based on the 2019 Society of Interventional Radiology consensus guidelines, have been reviewed and approved by all Duke IR attending physicians, but final decision is at the discretion of the attending physician or APP responsible for the case, as patient circumstances and procedural details can result in varying risk. For urgent circumstances, benefit of proceeding may outweigh risks of bleeding – furthermore, reversal agents may be available. For full details, please refer to the source document, available at http://sites.duke.edu/dukeir.
-"'For Neuroradiology Division guidelines'" (LP, spine biopsy, etc), see this document (updated July 2024): [[File:Anticoagulation Therapy Duke Spine Intervention July 2024.pdf]]
+'''For Neuroradiology Division guidelines''' (LP, spine biopsy, etc), see this document (updated July 2024): [[File:Anticoagulation Therapy Duke Spine Intervention July 2024.pdf]]
 == Procedural Bleeding Risk Categorization ==

@@ Line 22: / Line 22: @@
 These guidelines, based on the 2019 Society of Interventional Radiology consensus guidelines, have been reviewed and approved by all Duke IR attending physicians, but final decision is at the discretion of the attending physician or APP responsible for the case, as patient circumstances and procedural details can result in varying risk. For urgent circumstances, benefit of proceeding may outweigh risks of bleeding – furthermore, reversal agents may be available. For full details, please refer to the source document, available at http://sites.duke.edu/dukeir.
-For Neuroradiology Division guidelines (LP, spine biopsy, etc), see this document (updated July 2024): [[File:Anticoagulation Therapy Duke Spine Intervention July 2024.pdf]]
+''For Neuroradiology Division guidelines'' (LP, spine biopsy, etc), see this document (updated July 2024): [[File:Anticoagulation Therapy Duke Spine Intervention July 2024.pdf]]
 == Procedural Bleeding Risk Categorization ==